| Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization K Bajou, A Noël, RD Gerard, V Masson, N Brunner, C Holst-Hansen, ... Nature medicine 4 (8), 923, 1998 | 783 | 1998 |
| The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin: implications for antiangiogenic strategies K Bajou, V Masson, RD Gerard, PM Schmitt, V Albert, M Praus, LR Lund, ... The Journal of cell biology 152 (4), 777-784, 2001 | 372 | 2001 |
| The pro-or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent L Devy, S Blacher, C Grignet-Debrus, K Bajou, V Masson, RD Gerard, ... The FASEB Journal 16 (2), 147-154, 2002 | 297 | 2002 |
| Involvement of PA/plasmin system in the processing of pro‐MMP‐9 and in the second step of pro‐MMP‐2 activation EN Baramova, K Bajou, A Remacle, C L'hoir, HW Krell, UH Weidle, ... FEBS letters 405 (2), 157-162, 1997 | 289 | 1997 |
| The antitumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells A Hajitou, C Grignet, L Devy, S Berndt, S Blacher, CF Deroanne, K Bajou, ... The FASEB journal 16 (13), 1802-1804, 2002 | 237 | 2002 |
| Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes V Masson, LR de la Ballina, C Munaut, B Wielockx, M Jost, C Maillard, ... The FASEB Journal 19 (2), 234-236, 2005 | 188 | 2005 |
| Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth K Bajou, C Maillard, M Jost, RH Lijnen, A Gils, P Declerck, P Carmeliet, ... Oncogene 23 (41), 6986, 2004 | 178 | 2004 |
| Mouse aortic ring assay: a new approach of the molecular genetics of angiogenesis V Masson, L Devy, C Grignet-Debrus, S Bernt, K Bajou, S Blacher, ... Biological procedures online 4 (1), 24, 2002 | 141 | 2002 |
| Emerging roles for proteinases in cancer A Noël, C Gilles, K Bajou, L Devy, F Kebers, JM Lewalle, E Maquoi, ... Invasion and metastasis 17 (5), 221-39, 1997 | 139 | 1997 |
| Role of plasminogen activator-plasmin system in tumor angiogenesis JM Rakic, C Maillard, M Jost, K Bajou, V Masson, L Devy, V Lambert, ... Cellular and Molecular Life Sciences CMLS 60 (3), 463-473, 2003 | 134 | 2003 |
| Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis K Bajou, H Peng, WE Laug, C Maillard, A Noel, JM Foidart, JA Martial, ... Cancer cell 14 (4), 324-334, 2008 | 111 | 2008 |
| Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization V Lambert, C Munaut, A Noël, F Frankenne, K Bajou, R Gerard, ... The FASEB Journal 15 (6), 1021-1027, 2001 | 106 | 2001 |
| Alteration of Interendothelial Adherens Junctions Following Tumor Cell–Endothelial Cell Interactionin Vitro JM Lewalle, K Bajou, J Desreux, M Mareel, E Dejana, A Noël, JM Foidart Experimental cell research 237 (2), 347-356, 1997 | 55 | 1997 |
| Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization JM Rakic, V Lambert, C Munaut, K Bajou, K Peyrollier, ... Investigative ophthalmology & visual science 44 (4), 1732-1739, 2003 | 53 | 2003 |
| Host plasminogen activator inhibitor-1 promotes human skin carcinoma progression in a stage-dependent manner C Maillard, M Jost, MU Rømer, N Brunner, X Houard, A Lejeune, ... Neoplasia (New York, NY) 7 (1), 57, 2005 | 50 | 2005 |
| Endothelial cell intracellular Ca concentration is increased upon breast tumor cell contact and mediates tumor cell transendothelial migration JM Lewalle, D Cataldo, K Bajou, CA Lambert, JM Foidart Clinical & experimental metastasis 16 (1), 21-29, 1998 | 50 | 1998 |
| Human breast adenocarcinoma cell lines promote angiogenesis by providing cells with uPA‐PAI‐1 and by enhancing their expression K Bajou, JM Lewalle, CR Martinez, C Soria, H Lu, A Noël, JM Foidart International journal of cancer 100 (5), 501-506, 2002 | 47 | 2002 |
| PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin K Bajou, S Herkenne, VL Thijssen, S D'amico, A Bouché, S Tabruyn, ... Nature medicine 20 (7), 741, 2014 | 45 | 2014 |
| Interactions between endothelial cells and smooth muscle cells after their activation by hypoxia. A possible etiology for venous disease. C Michiels, T Arnould, D Janssens, K Bajou, I Geron, J Remacle International angiology: a journal of the International Union of Angiology …, 1996 | 37 | 1996 |
| New functions of stromal proteases and their inhibitors in tumor progression A Noël, V Albert, K Bajou, C Bisson, L Devy, F Frankenne, E Maquoi, ... Surgical oncology clinics of North America 10 (2), 417-432, 2001 | 33 | 2001 |